Diabetes News and Research

Latest Diabetes News and Research

Researchers identify phenomenon that explains effects of oxidative stress on immune cells

You're up in the mountains, the snow is blindingly white, and the sun is blazing down from the sky: ideal skiing conditions - but any skiers carrying the herpes virus might also have to reckon with the onset of cold sores after their day out.

10 Apr 2015

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.

9 Apr 2015

Study: Viagra, other related drugs not a universal 'cure-all' for impotence

Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester and NatCen Social Research.

9 Apr 2015

TABS study: Older people can improve their health by reducing sitting time

"I feel lethargic when I sit all day," said Gerald Alexander, an 82-year-old retired social service worker among the 25 Group Health patients who participated in the Take Active Breaks from Sitting (TABS) pilot study. "I feel much peppier when I stand and take walks."

9 Apr 2015

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 (“miR-103/107”) for the treatment of Non Alcoholic Steatohepatitis (“NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies’ strategic alliance to discover, develop and commercialize microRNA therapeutics.

9 Apr 2015

Countdown begins for 10th BIOVISION forum

The countdown begins with only one week to go until the life science event of the year. The BIOVISION forum is now in it’s 10th year, hosting over 1,500 attendees from the international health care and life sciences sector.

9 Apr 2015

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Patients hospitalized with advanced cirrhosis, a chronic and degenerative disease of the liver, are at increased risk of death. The tools currently used to assess that risk are limited in predicting which patients will need a liver transplant and which will be healthy enough to survive transplantation.

8 Apr 2015

Changes in height can affect risk of coronary heart disease

The shorter you are- the more your risk of coronary heart disease. That's the key finding of a new study led by the University of Leicester which discovered that every 2.5 inches change in your height affected your risk of coronary heart disease by 13.5%. For example, compared to a 5ft 6inch tall person, a 5 foot tall person on average has a 32% higher risk of coronary heart disease because of their relatively shorter stature.

8 Apr 2015

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.

8 Apr 2015

Exercise benefits obese, overweight people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the western world. A new study published in the Journal of Hepatology shows that exercise, regardless of frequency or intensity, benefits obese and overweight adults with NAFLD.

8 Apr 2015

UT researchers receive 2.5 million euros from European Commission for TransGeno project

The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.

8 Apr 2015

CUMC researchers identify cellular defect that could lead to potential new treatment for diabetes

A cellular defect that can impair the body's ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center researchers.

8 Apr 2015

New study could point to potential ways to address defects in learning, memory

Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills—running and memorizing—are not so different as it turns out.

8 Apr 2015

Study identifies gut immune system as new, effective target for diabetes

A commonly-used drug to treat inflammatory bowel disease, such as Crohn's disease, has been shown to lower blood sugar levels in obese mice, potentially identifying the gut immune system as a new and effective target in treating diabetes in humans.

8 Apr 2015

Livongo Health secures $20 million in Series B funding

Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.

7 Apr 2015

CVS Health Foundation announces new grant recipients to increase access to health care

The CVS Health Foundation, a private foundation created by CVS Health Corporation (NYSE: CVS), today announced 55 new grant recipients as part of its multi-year, $5 million commitment to increase access to health care in communities nationwide.

7 Apr 2015

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

Today in JAMA Pediatrics, researchers from The Children's Hospital of Philadelphia's (CHOP) PolicyLab published the largest study to date documenting the significant risks to children's health associated with prescription antipsychotics, a powerful a class of medications used to treat mental and behavioral health disorders.

7 Apr 2015

DreaMed Diabetes and Medtronic enter strategic collaboration

DreaMed Diabetes, developer of diabetes treatment and management solutions, announced today that it had signed an exclusive worldwide development and license agreement with Medtronic, the world's premier medical technology and services company, for the development and marketing of products incorporating DreaMed’s MD-Logic Artificial Pancreas algorithm in Medtronic’s insulin pumps.

From Medtronic 7 Apr 2015

Regular consumption of nuts reduce mortality by more than 20%

Nuts are a key element of a healthy diet. According to The World Health Organization (WHO), a healthy diet including nuts, regular exercise, the maintenance of ideal weight and staying away from tobacco and alcohol could be sufficient to prevent cancer cases.

6 Apr 2015

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Results from the largest clinical trial to date, comparing non-invasive prenatal testing (NIPT) using the Harmony Prenatal Test with conventional first trimester combined screening (FTS) in a general pregnancy population have been published online in The New England Journal of Medicine.

6 Apr 2015

Diabetes News and Research

Latest Diabetes News and Research

Researchers identify phenomenon that explains effects of oxidative stress on immune cells

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

Study: Viagra, other related drugs not a universal 'cure-all' for impotence

TABS study: Older people can improve their health by reducing sitting time

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Countdown begins for 10th BIOVISION forum

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Changes in height can affect risk of coronary heart disease

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Exercise benefits obese, overweight people with NAFLD

UT researchers receive 2.5 million euros from European Commission for TransGeno project

CUMC researchers identify cellular defect that could lead to potential new treatment for diabetes

New study could point to potential ways to address defects in learning, memory

Study identifies gut immune system as new, effective target for diabetes

Livongo Health secures $20 million in Series B funding

CVS Health Foundation announces new grant recipients to increase access to health care

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

DreaMed Diabetes and Medtronic enter strategic collaboration

Regular consumption of nuts reduce mortality by more than 20%

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in